Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Group 1:Immunotherapy
2 trials
Sponsors
The Fifth Affiliated Hospital of Sun Yat-Sen University
, Shanghai Pulmonary Hospital
Conditions
Lung Cancer
non-small-cell lung carcinoma
Early Phase 1
A multicenter, open and prospective study on the effect of immunotherapy on T cell surface receptors and cytokines in non-small-cell lung carcinoma
Recruiting
ChiCTR2000030174
The Fifth Affiliated Hospital of Sun Yat-Sen University
non-small-cell lung carcinoma
Start: 2020-03-01
Updated: 2020-02-25
Phase 2
Ablation plus immunotherapy versus immunotherapy alone in advanced non-small cell lung cancer patients with oligoresidual disease after first-line immunotherapy: an open-label, randomised, controlled phase II trial
Recruiting
ChiCTR2000032479
Shanghai Pulmonary Hospital
Lung Cancer
Start: 2021-03-03
Updated: 2025-05-05
Related Papers
Ablation plus immunotherapy in advanced NSCLC patients who develop oligo-residual disease after anti–PD-1/L1 therapy: Updated results from the BOOSTER trial.
Journal of Clinical Oncology
2026-05-28
Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1/L1 therapy (BOOSTER): a randomized phase 2 trial.
2025-11-11